Wattanathorn, J.; Thukham-mee, W.; Tong-un, T.; Sangartit, W.; Somboonporn, W.; Paholpak, P.
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 8-Week Pilot Study of Tuna-Byproduct-Derived Novel Supplements for Managing Cellular Senescence and Cognitive Decline in Perimenopausal and Postmenopausal Women. Antioxidants 2025, 14, 520.
https://doi.org/10.3390/antiox14050520
AMA Style
Wattanathorn J, Thukham-mee W, Tong-un T, Sangartit W, Somboonporn W, Paholpak P.
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 8-Week Pilot Study of Tuna-Byproduct-Derived Novel Supplements for Managing Cellular Senescence and Cognitive Decline in Perimenopausal and Postmenopausal Women. Antioxidants. 2025; 14(5):520.
https://doi.org/10.3390/antiox14050520
Chicago/Turabian Style
Wattanathorn, Jintanaporn, Wipawee Thukham-mee, Terdthai Tong-un, Weerapon Sangartit, Woraluck Somboonporn, and Pongsatorn Paholpak.
2025. "A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 8-Week Pilot Study of Tuna-Byproduct-Derived Novel Supplements for Managing Cellular Senescence and Cognitive Decline in Perimenopausal and Postmenopausal Women" Antioxidants 14, no. 5: 520.
https://doi.org/10.3390/antiox14050520
APA Style
Wattanathorn, J., Thukham-mee, W., Tong-un, T., Sangartit, W., Somboonporn, W., & Paholpak, P.
(2025). A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 8-Week Pilot Study of Tuna-Byproduct-Derived Novel Supplements for Managing Cellular Senescence and Cognitive Decline in Perimenopausal and Postmenopausal Women. Antioxidants, 14(5), 520.
https://doi.org/10.3390/antiox14050520
